Right drug, right dosage, right away
ImpeDx, co-founded by Mizzou Engineering’s Shramik Sengupta, recently received a National Science Foundation (NSF) SBIR Phase II grant and CDC contract.
ImpeDx, co-founded by Mizzou Engineering’s Shramik Sengupta, recently received a National Science Foundation (NSF) SBIR Phase II grant and CDC contract.